COURT-RULING ·Filed Mar 30, 2026
Court ruling (district)
Actionable Insight • Neutral
Monitor for subsequent filings or docket updates in this case for material developments; current filing appears to be a placeholder or access-restricted document
Final — all horizons settled through T+60d ⚠ clustered
NVS ▲ +3.17% at T+60d
NEUTRAL call +3.17% · α vs SPY -13.33% · entry $150.36 → $155.12
T+1d
+1.59%
call +1.59% · α -1.30%
$152.75
settled 7mo ago
T+5d
+0.57%
call +0.57% · α -3.73%
$151.22
settled 7mo ago
T+20d
-3.23%
call -3.23% · α -15.83%
$145.50
settled 6mo ago
T+60d
+3.17%
call +3.17% · α -13.33%
$155.12
settled 4mo ago
Price Chart
Loading chart...
Executive Summary
Analysis based on filing metadata only — document content was unavailable
Court Ruling Details
Court
United States District Court for the District of Delaware
Court Level
District
Case Type
patent
Precedent Risk
LOW
Key Facts
- Case involves Novartis Pharmaceuticals Corporation (NVS) as plaintiff against Cipla USA Inc. in the District of Delaware
- Filed on 2026-03-30, case status is unknown
- No substantive ruling text available — only metadata and login redirect present
Financial Impact
Unknown — no financial terms or damages disclosed
Risk Factors
- Potential IP or patent dispute between pharmaceutical companies, which could affect drug exclusivity if resolved adversely
- Uncertainty due to lack of accessible ruling details
Market Snapshot
Exchange
OTC
Sector
Pharmaceutical Preparations
Investment Themes
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-wsf64gyy-NVS |
13 reports for NVS
67% Hit rate @ T+1 Went positive at some point 5 of 6 best @ T+60▲ +6.86%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 6-K | $156.18 | awaiting T+1 | — | $156.86 (+0.44%) |
Oct 15, 2026 13d ago | Court Ruling | $150.62 $150.20 | ▼ −0.28% | ▼ −0.70% | $156.86 (+4.14%) |
Oct 13, 2026 15d ago | Court Ruling | $146.88 $150.38 | ▼ −2.38% | ▼ −2.10% | $156.86 (−6.79%) |
Sep 22, 2026 5w ago | Institutional Cluster | $141.28 $142.71 | ▲ +1.01% | ▲ +1.73% | $156.86 (+11.03%) |
Sep 4, 2026 7w ago | 6-K | $137.70 $137.48 | ▲ +0.16% | ▼ −0.30% | $156.86 (−13.91%) |
Sep 1, 2026 8w ago | 6-K | $161.25 $162.46 | ▲ +0.75% | ▲ +0.31% | $156.86 (−2.72%) |
Aug 4, 2026 12w ago | Court Ruling | $154.44 $154.21 | ▼ −0.15% | ▲ +0.01% | $156.86 (+1.57%) |
Jul 28, 2026 13w ago | Court Ruling | $158.83 $158.44 | ▼ −0.25% | ▼ −1.92% | $156.86 (−1.24%) |
Jul 21, 2026 14w ago | 6-K | $153.87 $153.08 | ▼ −0.51% | ▼ −0.40% | $156.86 (+1.94%) |
Jul 1, 2026 17w ago | Court Ruling | $154.14 $159.90 | ▼ −3.74% | ▼ −3.87% | $156.86 (−1.76%) |
Showing 10 of 13
US Market Status
Market Closed — Opens in 8h 9m
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers